Market Overview

Stimwave Names Industry Veterans Paul LaViolette and Jeffrey Goldberg to Board of Directors


Stimwave LLC, a medical device manufacturer
and independent research institute headquartered in South Florida,
announced today that Paul LaViolette, managing partner and chief
operating officer of SV Health Investors and former COO of Boston
Scientific, and Jeff Goldberg, former president of Al Mann's
medical-technology incubator, joined Stimwave's Board of Directors.

"Paul is an inspirational thought leader who has helped grow companies
who were disruptive in health care into multi-billion dollar
enterprises, while improving the lives of millions," said Stimwave
Chairman and CEO of Laura Tyler Perryman. "He will be an outstanding
addition to our board."

LaViolette built and ran medical device businesses for 29 years, and he
was chief operating officer at Boston Scientific (BSC). During his
tenure, the company grew revenue over 20 times. He integrated two dozen
acquisitions and led extensive product development, manufacturing and
worldwide commercial organizations.

"It's an honor and a privilege to come aboard with Stimwave as it
deploys its innovative technology to market," said LaViolette. "Medical
devices focused on increased access, minimal invasiveness and state of
the art technology are the future of health care, and Stimwave is well
positioned to expand the neuromodulation market."

"Jeff Goldberg served a critical role within Al Mann's enterprises for
many years, and Stimwave holds the same principles of creating a
technology platform that can benefit patients' lives, while increasing
the market considerably by reimagining how we deliver neuromodulation,"
said Perryman. "Familiarity with industry disruptor products such as
Stimwave will be invaluable to our future growth plans as we continue to
transform our business at an accelerated pace."

Goldberg has been an executive and advisor in the health care industry
for over 25 years. Recently, he served as chair of the board of
Angiotech Pharmaceuticals and Physiotherapy Associates and is now
serving as chair of the board of 21st Century Oncology, LifeCare Health
Partners, Corizon Health, and M*Modal.

"The opportunity to treat pain without implanting a large battery, like
what Laura and the Stimwave team are offering patients and their
physicians, represents the same type of dramatic innovation that
characterized Al Mann's most successful companies," Goldberg said. "I am
honored to work with as creative and dynamic a leader with Laura and
look forward to our journey together."

Stimwave's devices are the premier wireless stimulators, using Wireless
Pain Relief® technology that allows them to be 95 percent
smaller than any other neuromodulation device on the market. These
devices treat back and leg pain, as well as treatment for shoulder pain,
wrist and elbow pain, knee pain, hip pain and more.

About Stimwave LLC

Stimwave LLC is a privately held medical device company engaged in the
development, manufacturing, and commercialization of wirelessly powered,
microtechnology neurostimulators, providing patients with a convenient,
safe, minimally invasive, and highly cost-effective pain management
solution that is easily incorporated into their daily lives. Stimwave's
goal is to evolve its patented, cutting-edge platform into the default
for neuromodulation, increasing the accessibility for patients worldwide
while lowering the economic impact of pain management.

View Comments and Join the Discussion!